Arteriovenous Access for Hemodialysis
Authors:
Top Cited Papers
- 16 April 2024
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 331 (15) , 1307-1317
Abstract
Importance: Hemodialysis requires reliable vascular access to the patient’s blood circulation, such as an arteriovenous access in the form of an autogenous arteriovenous fistula or nonautogenous arteriovenous graft. This Review addresses key issues associated with the construction and maintenance of hemodialysis arteriovenous access.Observations: All patients with kidney failure should have an individualized strategy (known as Patient Life-Plan, Access Needs, or PLAN) for kidney replacement therapy and dialysis access, including contingency plans for access failure. Patients should be referred for hemodialysis access when their estimated glomerular filtration rate progressively decreases to 15 to 20 mL/min, or when their peritoneal dialysis, kidney transplant, or current vascular access is failing. Patients with chronic kidney disease should limit or avoid vascular procedures that may complicate future arteriovenous access, such as antecubital venipuncture or peripheral insertion of central catheters. Autogenous arteriovenous fistulas require 3 to 6 months to mature, whereas standard arteriovenous grafts can be used 2 to 4 weeks after being established, and “early-cannulation” grafts can be used within 24 to 72 hours of creation. The prime pathologic lesion of flow-related complications of arteriovenous access is intimal hyperplasia within the arteriovenous access that can lead to stenosis, maturation failure (33%-62% at 6 months), or poor patency (60%-63% at 2 years) and suboptimal dialysis. Nonflow complications such as access-related hand ischemia (“steal syndrome”; 1%-8% of patients) and arteriovenous access infection require timely identification and treatment. An arteriovenous access at high risk of hemorrhaging is a surgical emergency.Conclusions and Relevance: The selection, creation, and maintenance of arteriovenous access for hemodialysis vascular access is critical for patients with kidney failure. Generalist clinicians play an important role in protecting current and future arteriovenous access; identifying arteriovenous access complications such as infection, steal syndrome, and high-output cardiac failure; and making timely referrals to facilitate arteriovenous access creation and treatment of arteriovenous access complications.Keywords
This publication has 87 references indexed in Scilit:
- Dialysis Access-Associated Steal Syndrome and ManagementCardioVascular and Interventional Radiology, 2023
- Central Line Access for Hemodialysis Adversely Affects Ipsilateral Arteriovenous Graft OutcomesAnnals of Vascular Surgery, 2022
- Arteriovenous Fistula Aneurysm: Bench to BedsideIndian Journal of Surgery, 2022
- Risk Factors and Management of Hemodialysis Associated Distal IschemiaAnnals of Vascular Surgery, 2021
- Arteriovenous Fistula Maturation, Functional Patency, and Intervention RatesJAMA Surgery, 2021
- Drug-Eluting Balloon Versus Plain Balloon Angioplasty For The Treatment of Failing Hemodialysis Access: A Systematic Review and Meta-analysisAnnals of Vascular Surgery, 2020
- Comparison of Percutaneous Transluminal Angioplasty with Stenting for Treatment of Central Venous Stenosis or Occlusion in Hemodialysis Patients: A Systematic Review and Meta-analysisCardioVascular and Interventional Radiology, 2020
- Effect of high flow arteriovenous fistula on cardiac function in hemodialysis patientsThe Egyptian Heart Journal, 2018
- Pre-emptive correction for haemodialysis arteriovenous access stenosisCochrane Database of Systematic Reviews, 2016
- Effect of Fish Oil Supplementation on Graft Patency and Cardiovascular Events Among Patients With New Synthetic Arteriovenous Hemodialysis GraftsJAMA, 2012